John H. Leung

TPQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Efficacy and Safety of Stereotactic Body Radiation Therapy Modalities for >5 cm Advanced Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis.

Efficacy and Safety of Stereotactic Body Radiation Therapy Modalities for >5 cm Advanced Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis.

Journal: Cancers

Published: February 19, 2026

Efficacy and Safety of Different Treatments for Melasma: Network Meta-Analysis of Updated Data.

Efficacy and Safety of Different Treatments for Melasma: Network Meta-Analysis of Updated Data.

Journal: Diseases (Basel, Switzerland)

Published: August 08, 2025

Association of Pregnancy Complications with Endometrial or Ovarian or Breast Cancer: A Case Control Study.

Association of Pregnancy Complications with Endometrial or Ovarian or Breast Cancer: A Case Control Study.

Journal: Medicina (Kaunas, Lithuania)

Published: November 04, 2024

Association of Granulocyte Colony-Stimulating Factor Treatment with Risk of Brain Metastasis in Advanced Stage Breast Cancer.

Association of Granulocyte Colony-Stimulating Factor Treatment with Risk of Brain Metastasis in Advanced Stage Breast Cancer.

Journal: International journal of molecular sciences

Published: August 31, 2024

Comparison of target agent treatment strategies for platinum-resistant recurrent ovarian cancer: A Bayesian network meta-analysis.

Comparison of target agent treatment strategies for platinum-resistant recurrent ovarian cancer: A Bayesian network meta-analysis.

Journal: Medicine

Published: May 24, 2024

Cost-effectiveness and drug wastage of bevacizumab biosimilar with or without chemotherapy for platinum-resistant recurrent ovarian cancer.

Cost-effectiveness and drug wastage of bevacizumab biosimilar with or without chemotherapy for platinum-resistant recurrent ovarian cancer.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: February 19, 2024

Comparative efficacy and safety of multimodality treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: patient-level network meta-analysis.

Comparative efficacy and safety of multimodality treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: patient-level network meta-analysis.

Journal: Frontiers in oncology

Published: November 26, 2023

Hypothyroidism and hyperthyroidism related to gynecologic cancers: a nationwide population-based cohort study.

Hypothyroidism and hyperthyroidism related to gynecologic cancers: a nationwide population-based cohort study.

Journal: Scientific reports

Published: April 11, 2023

Comparative Efficacy and safety of new targeted therapies and immunotherapies for metastatic triple negative breast cancer: a network meta-analysis.

Comparative Efficacy and safety of new targeted therapies and immunotherapies for metastatic triple negative breast cancer: a network meta-analysis.

Journal: Expert opinion on drug safety

Published: August 23, 2022

Cost-effectiveness of immune checkpoint inhibitors in the treatment of non-small-cell lung cancer as a second line in Taiwan.

Cost-effectiveness of immune checkpoint inhibitors in the treatment of non-small-cell lung cancer as a second line in Taiwan.

Journal: Future oncology (London, England)

Published: February 02, 2022

Cost-effectiveness of trastuzumab biosimilar combination therapy and drug wastage as first-line treatment for HER2-positive metastatic breast cancer.

Cost-effectiveness of trastuzumab biosimilar combination therapy and drug wastage as first-line treatment for HER2-positive metastatic breast cancer.

Journal: Breast (Edinburgh, Scotland)

Published: December 03, 2021

Cost-effectiveness analysis of olaparib and niraparib as maintenance therapy for women with recurrent platinum-sensitive ovarian cancer.

Cost-effectiveness analysis of olaparib and niraparib as maintenance therapy for women with recurrent platinum-sensitive ovarian cancer.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: July 09, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026